Brief: Herantis Pharma H1 Loss Narrows To EUR 5.7 Million

Herantis Pharma Oyj

25/08/2022 06:11

Aug 25 (Reuters) - Herantis Pharma Oyj  HRTIS.HE :
    * HERANTIS PHARMA OYJ -
    * HERANTIS PUBLISHES 1H REPORT FOR 2022
    * H1 LOSS FOR PERIOD EUR 5.7 MILLION VERSUS LOSS EUR 7.9
MILLION
YEAR AGO

Source text for Eikon:  ID:nWkr2HytVP 
Further company coverage:  HRTIS.HE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))